Free Trial

Biotricity (BTCY) Short Interest Ratio & Short Volume

Biotricity logo
$0.36
-0.05 (-12.27%)
(As of 11/4/2024 ET)

Biotricity Short Interest Data

Biotricity (BTCY) has a short interest of 246,700 shares. This marks a 11.18% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 76,398 shares to cover all short positions.

Current Short Interest
246,700 shares
Previous Short Interest
221,900 shares
Change Vs. Previous Month
+11.18%
Dollar Volume Sold Short
$64,142.00
Short Interest Ratio
1.3 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
22,615,000 shares
Percentage of Shares Shorted
1.09%
Today's Trading Volume
135,217 shares
Average Trading Volume
76,398 shares
Today's Volume Vs. Average
177%
Short Selling Biotricity?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Biotricity and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BTCY Short Interest Over Time

BTCY Days to Cover Over Time

BTCY Percentage of Float Shorted Over Time

Biotricity Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024246,700 shares $64,142.00 +11.2%N/A1.3 $0.26
9/30/2024221,900 shares $52,168.69 -2.6%N/A3.1 $0.24
9/15/2024227,800 shares $88,614.20 -21.8%N/A5.6 $0.39
8/31/2024291,100 shares $120,643.48 -4.4%N/A2.9 $0.41
8/15/2024304,600 shares $127,932.00 -37.5%N/A1.2 $0.42
8/13/202172,200 shares $257,754.00 No ChangeN/A0.7 $3.57
7/30/202172,200 shares $265,696.00 -9.8%N/A1.3 $3.68
7/15/202180,000 shares $299,200.00 +82.7%N/A0.6 $3.74
6/30/202143,800 shares $137,751.00 -4.6%N/A0.2 $3.15
6/15/202145,900 shares $183,600.00 +21.8%N/A0.2 $4.00
5/28/202137,700 shares $104,617.50 +70.6%N/A0.2 $2.78
5/14/202122,100 shares $46,410.00 -33.6%N/A0.2 $2.10
4/30/202133,300 shares $68,265.00 +160.2%N/A0.2 $2.05
4/15/202112,800 shares $31,616.00 -6.6%N/A0.2 $2.47
3/31/202113,700 shares $32,195.00 -3.5%N/A0.1 $2.35
3/15/202114,200 shares $35,500.00 +10.1%N/A0 $2.50
2/26/202112,900 shares $26,961.00 +8.4%N/A0.1 $2.09
2/12/202111,900 shares $20,349.00 +8.2%N/A0.1 $1.71
1/29/202111,000 shares $13,090.00 -22.0%N/A0.1 $1.19
1/15/20214,800 shares $5,472.00 -72.3%N/A0.1 $1.14
12/31/202012,100 shares $8,833.00 +152.1%N/A0.1 $0.73
12/15/20204,800 shares $3,552.00 -72.3%N/A0.1 $0.74
11/30/202017,300 shares $12,456.00 +76.5%N/A0.1 $0.72
11/15/20209,800 shares $9,800.00 -13.3%N/A0.1 $1.00
10/30/202011,300 shares $11,300.00 +56.9%N/A0.2 $1.00
10/15/20207,200 shares $7,560.00 -25.8%N/A0.2 $1.05
9/30/20209,700 shares $10,767.00 +977.8%N/A0.3 $1.11
9/15/2020900 shares $1,035.00 -93.7%N/A0 $1.15
8/31/202014,300 shares $19,734.00 +30.0%N/A0.1 $1.38
8/14/202011,000 shares $15,620.00 +1,471.4%N/A0.1 $1.42
7/31/2020700 shares $980.00 -68.2%N/A0 $1.40
7/15/20202,200 shares $3,366.00 -59.3%N/A0 $1.53
6/30/20205,400 shares $7,381.80 -15.6%N/A0.1 $1.37
6/15/20206,400 shares $9,280.00 -89.6%N/A0.1 $1.45
5/29/202061,700 shares $95,018.00 +8.6%N/A0.2 $1.54
5/15/202056,800 shares $68,160.00 -1.9%N/A0.8 $1.20
4/30/202057,900 shares $75,270.00 +0.7%N/A0.3 $1.30
4/15/202057,500 shares $55,200.00 -16.6%N/A0.5 $0.96
3/31/202068,900 shares $67,108.60 -18.1%N/A0.6 $0.97
3/13/202084,100 shares $93,351.00 -8.9%N/A0.7 $1.11
The Final Frontier (Ad)

And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.

2/28/202092,300 shares $129,220.00 +6.0%N/A0.2 $1.40
2/14/202087,100 shares $108,875.00 +3,250.0%N/A0.2 $1.25
1/31/20202,600 shares $2,990.00 -70.5%N/A0 $1.15
1/15/20208,800 shares $14,960.00 -5.4%N/A0.2 $1.70
12/31/20199,300 shares $6,975.00 +365.0%N/A0 $0.75

BTCY Short Interest - Frequently Asked Questions

What is Biotricity's current short interest?

Short interest is the volume of Biotricity shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 246,700 shares of BTCY short. Learn More on Biotricity's current short interest.

What is a good short interest ratio for Biotricity?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BTCY shares currently have a short interest ratio of 1.0. Learn More on Biotricity's short interest ratio.

Is Biotricity's short interest increasing or decreasing?

Biotricity saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 246,700 shares, an increase of 11.2% from the previous total of 221,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Biotricity's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "medical equipment" compare to Biotricity: Co-Diagnostics, Inc. (0.71%), SurgePays, Inc. (3.63%), United Health Products, Inc. (0.04%), Femasys Inc. (2.42%), Neuronetics, Inc. (2.35%), Outset Medical, Inc. (6.66%), DarioHealth Corp. (5.62%), Nexalin Technology, Inc. (1.15%), IRIDEX Co. (2.71%), Vaso Co. (0.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Biotricity stock?

Short selling BTCY is an investing strategy that aims to generate trading profit from Biotricity as its price is falling. BTCY shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Biotricity?

A short squeeze for Biotricity occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BTCY, which in turn drives the price of the stock up even further.

How often is Biotricity's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTCY, twice per month. The most recent reporting period available is October, 15 2024.




This page (OTCMKTS:BTCY) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners